322 related articles for article (PubMed ID: 30276966)
121. Relevance of STK11 Mutations Regarding Immune Cell Infiltration, Drug Sensitivity, and Cellular Processes in Lung Adenocarcinoma.
Li Z; Ding B; Xu J; Mao K; Zhang P; Xue Q
Front Oncol; 2020; 10():580027. PubMed ID: 33425731
[TBL] [Abstract][Full Text] [Related]
122. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
[TBL] [Abstract][Full Text] [Related]
123. An integrative analysis of DNA methylation and transcriptome showed the dysfunction of MAPK pathway was involved in the damage of human chondrocyte induced by T-2 toxin.
Yang X; Xiao X; Zhang L; Wang B; Li P; Cheng B; Liang C; Ma M; Guo X; Zhang F; Wen Y
BMC Mol Cell Biol; 2022 Jan; 23(1):4. PubMed ID: 35038982
[TBL] [Abstract][Full Text] [Related]
124. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
Zeng JH; Xiong DD; Pang YY; Zhang Y; Tang RX; Luo DZ; Chen G
Oncotarget; 2017 May; 8(22):35681-35699. PubMed ID: 28415685
[TBL] [Abstract][Full Text] [Related]
125. Identification of Key Transcription Factors Associated with Lung Squamous Cell Carcinoma.
Zhang F; Chen X; Wei K; Liu D; Xu X; Zhang X; Shi H
Med Sci Monit; 2017 Jan; 23():172-206. PubMed ID: 28081052
[TBL] [Abstract][Full Text] [Related]
126. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.
Qu T; Li YP; Li XH; Chen Y
Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685
[TBL] [Abstract][Full Text] [Related]
127. Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.
Melocchi V; Dama E; Mazzarelli F; Cuttano R; Colangelo T; Di Candia L; Lugli E; Veronesi G; Pelosi G; Ferretti GM; Taurchini M; Graziano P; Bianchi F
Oncogene; 2021 Aug; 40(31):4980-4991. PubMed ID: 34172935
[TBL] [Abstract][Full Text] [Related]
128. Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma.
Liang X; Chen Y; Fan Y
Environ Sci Pollut Res Int; 2022 Mar; 29(15):22012-22030. PubMed ID: 34775559
[TBL] [Abstract][Full Text] [Related]
129. Prognostic Impact of
Guo W; Huai Q; Wan H; Guo L; Song P; Gao S; He J
DNA Cell Biol; 2021 Feb; 40(2):316-331. PubMed ID: 33493403
[TBL] [Abstract][Full Text] [Related]
130. Integrated analysis reveals candidate genes and transcription factors in lung adenocarcinoma.
Chen B; Gao S; Ji C; Song G
Mol Med Rep; 2017 Dec; 16(6):8371-8379. PubMed ID: 28983631
[TBL] [Abstract][Full Text] [Related]
131. Prognosis genes in gastric adenocarcinoma identified by cross talk genes in disease‑related pathways.
Zhao L; Lei H; Shen L; Tang J; Wang Z; Bai W; Zhang F; Wang S; Li W
Mol Med Rep; 2017 Aug; 16(2):1232-1240. PubMed ID: 28586067
[TBL] [Abstract][Full Text] [Related]
132. Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.
Wang Q; Li M; Yang M; Yang Y; Song F; Zhang W; Li X; Chen K
Aging (Albany NY); 2020 Feb; 12(4):3312-3339. PubMed ID: 32091408
[TBL] [Abstract][Full Text] [Related]
133. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
[TBL] [Abstract][Full Text] [Related]
134. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Luo B; Gu YY; Wang XD; Chen G; Peng ZG
Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
[TBL] [Abstract][Full Text] [Related]
135. Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq.
Huang Y; Pan J; Chen D; Zheng J; Qiu F; Li F; Wu Y; Wu W; Huang X; Qian J
Oncotarget; 2017 May; 8(22):35973-35983. PubMed ID: 28415592
[TBL] [Abstract][Full Text] [Related]
136. Bioinformatics methods for identifying differentially expressed genes and signaling pathways in nano-silica stimulated macrophages.
Zhang L; Hao C; Li J; Qu Y; Bao L; Li Y; Yue Z; Zhang M; Yu X; Chen H; Zhang J; Wang D; Yao W
Tumour Biol; 2017 Jun; 39(6):1010428317709284. PubMed ID: 28653889
[TBL] [Abstract][Full Text] [Related]
137. Genome-wide analysis reveals alcohol dehydrogenase 1C and secreted phosphoprotein 1 for prognostic biomarkers in lung adenocarcinoma.
Shen XY; Liu XP; Song CK; Wang YJ; Li S; Hu WD
J Cell Physiol; 2019 Dec; 234(12):22311-22320. PubMed ID: 31074035
[TBL] [Abstract][Full Text] [Related]
138. Transcriptome and DNA Methylation Analyses of the Molecular Mechanisms Underlying with Longissimus dorsi Muscles at Different Stages of Development in the Polled Yak.
Ma X; Jia C; Chu M; Fu D; Lei Q; Ding X; Wu X; Guo X; Pei J; Bao P; Yan P; Liang C
Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31779203
[TBL] [Abstract][Full Text] [Related]
139. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
Zhang JT; Lin YC; Xiao BF; Yu BT
Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
[TBL] [Abstract][Full Text] [Related]
140. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
Hu C; Zhou Y; Liu C; Kang Y
Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
